BORDERLINE SEROUS TUMOUR OF OVARY

BORDERLINE SEROUS TUMOUR OF OVARY was reported 31 times

BORDERLINE SEROUS TUMOUR OF OVARY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Androgen [EPC] 7 0.0003
1 Aromatase Inhibitor [EPC] 2 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
4 Integrin Receptor Antagonist [EPC] 1 0.0000
5 Purine Antimetabolite [EPC] 1 0.0000
6 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
7 Progestin [EPC] 2 0.0000
8 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
9 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
10 Kinase Inhibitor [EPC] 3 0.0000
11 Interferon beta [EPC] 1 0.0000
12 Thiazide Diuretic [EPC] 1 0.0000
13 Alkylating Drug [EPC] 1 0.0000
14 Platinum-based Drug [EPC] 1 0.0000
15 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000